关注
Bethany Hannafon, Ph.D.
Bethany Hannafon, Ph.D.
University of Oklahoma Health Sciences Center
在 ouhsc.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Plasma exosome microRNAs are indicative of breast cancer
BN Hannafon, YD Trigoso, CL Calloway, YD Zhao, DH Lum, AL Welm, ...
Breast cancer research 18, 1-14, 2016
5622016
Intercellular communication by exosome-derived microRNAs in cancer
BN Hannafon, WQ Ding
International journal of molecular sciences 14 (7), 14240-14269, 2013
5542013
Chloroquine is a zinc ionophore
J Xue, A Moyer, B Peng, J Wu, BN Hannafon, WQ Ding
PloS one 9 (10), e109180, 2014
3042014
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)
BN Hannafon, KJ Carpenter, WL Berry, R Janknecht, WC Dooley, ...
Molecular cancer 14, 1-13, 2015
2332015
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer
BN Hannafon, P Sebastiani, A de las Morenas, J Lu, CL Rosenberg
Breast cancer research 13, 1-14, 2011
2002011
Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer
YF Xu, BN Hannafon, YD Zhao, RG Postier, WQ Ding
Oncotarget 8 (44), 77028, 2017
1692017
Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria
T Liu, B Hannafon, L Gill, W Kelly, D Benbrook
Molecular cancer therapeutics 6 (6), 1814-1822, 2007
1102007
Disulfiram's anticancer activity: evidence and mechanisms
Y Jiao, B N Hannafon, WQ Ding
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016
1012016
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study
BN Hannafon, A Cai, CL Calloway, YF Xu, R Zhang, KM Fung, WQ Ding
BMC cancer 19, 1-12, 2019
1002019
Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists
DM Benbrook, SA Kamelle, SB Guruswamy, SA Lightfoot, TL Rutledge, ...
Investigational new drugs 23, 417-428, 2005
682005
The origin of exosomal miR-1246 in human cancer cells
YF Xu, BN Hannafon, U Khatri, A Gin, WQ Ding
RNA biology 16 (6), 770-784, 2019
632019
Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells
BN Hannafon, AL Gin, YF Xu, M Bruns, CL Calloway, WQ Ding
Cell Communication and Signaling 17, 1-13, 2019
582019
microRNA regulation of human pancreatic cancer stem cells
YF Xu, BN Hannafon, WQ Ding
Stem cell investigation 4, 2017
432017
Cancer stem cells and exosome signaling
BN Hannafon, WQ Ding
Stem cell investigation 2, 2015
352015
Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: The involvement of the Wnt/β-catenin signaling pathway
S Wang, JE Avery, BN Hannafon, SE Lind, WQ Ding
Biochemical pharmacology 85 (11), 1611-1618, 2013
322013
Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions
Y Jiao, BN Hannafon, RR Zhang, KM Fung, WQ Ding
Oncotarget 8 (11), 17908, 2017
312017
SRSF1 regulates exosome microRNA enrichment in human cancer cells
YF Xu, X Xu, A Gin, JD Nshimiyimana, BHM Mooers, M Caputi, ...
Cell Communication and Signaling 18, 1-13, 2020
292020
Functional role of miRNAs in the progression of breast ductal carcinoma in situ
BN Hannafon, WQ Ding
The American Journal of Pathology 189 (5), 966-974, 2019
272019
Characterization of docosahexaenoic acid (DHA)-induced heme oxygenase-1 (HO-1) expression in human cancer cells: the importance of enhanced BTB and CNC homology 1 (Bach1 …
S Wang, BN Hannafon, RF Wolf, J Zhou, JE Avery, J Wu, SE Lind, ...
The journal of nutritional biochemistry 25 (5), 515-525, 2014
252014
miRNAs as biomarkers for predicting the progression of ductal carcinoma in situ
BN Hannafon, WQ Ding
The American Journal of Pathology 188 (3), 542-549, 2018
232018
系统目前无法执行此操作,请稍后再试。
文章 1–20